Connect with us

Cannabis News

South Dakota Legislative Panel Recommends Tighter Regulations On Medical Marijuana And Hemp Products

Published

on

“This commission, in my opinion, has only made it harder for patients to get access to medical cannabis.”

The A rift between a South Dakota oversight board and the state’s medical marijuana industry It unfolded in Pierre on Tuesday, when the commission passed 11 motions, some of which called for stricter regulations.

The motions were not made public prior to the meeting, and the committee did not take public comment on individual motions. The committee acted on the motions, with four of the 11 members of the group not present.

The intentions of the Medical Marijuana Oversight Committee to propose and pass some of the motions were unclear. The motions were not introduced as formal proposals to change the rules or as bills for the legislative session, which begins in January.

The themes of the motions varied widely and included recommendations for stricter regulation of the medical marijuana industry, and intoxicating products sold outside the industry in convenience stores and statements of support or recommendations on smoke shops and other topics.

“I think these are just motions, right?” said Sen. Lauren Nelson, R-Yankton, a committee member. “So some of these motions that passed today may never be heard again. Some of these motions may become bills that one of us, someone else in the Legislature, can carry, and then we can have our debate.”

Medical marijuana industry lobbyist Jeremiah Murphy asked that the minutes reflect that no prior public notice of the motions was given and no public comment was made on the individual motions.

“If you want to just call these ‘motions’, that’s fine,” Murphy said, “But the key is that they’re not considered anything like legislation because they weren’t published beforehand. The bill or resolution has to be published before the hearing.”

The votes ended a combative meeting that was similar in tone to the commission’s previous meeting two weeks ago. That earlier meeting drew industry complaints about a guest speaker list that presented mostly negative views on marijuana.

of the committee membership It consists of four members of parliament and seven non-legislators, including members of the medical, counseling, law enforcement and patient communities. The committee members missing Tuesday were all nonlegislators: Francine Arneson, Kristi Palmer, Andrew Schock and Sioux Falls Police Chief Jon Thum.

At the end of Tuesday’s meeting, the commission took public comments from individuals, each limited to two minutes.

Kittrick Jeffries, of Puffy’s Dispensary in Rapid City, said the panel “was clarifying issues that voters decided five years ago.” South Dakota voters legalized medical marijuana in 2020, and the state implemented the program in 2022. There are 17,137 sick card holders in the state.

“This commission, in my view, has only made it harder for patients to get access to medical cannabis,” Jeffries said.

Emmett Reistroffer, with Genesis Farms Cannabis Company, called the panel a “show committee” and questioned the motivation of Rep. Josephine Garcia, R-Watertown, who said she sponsored unsuccessful legislation earlier this year to repeal the state’s medical marijuana program.

“I don’t think there’s any business running an oversight committee on a program that you publicly opposed in the last legislative session,” Reistroffer said. “Of course you don’t like what I have to say, but I have two minutes. I’m a citizen of the state of South Dakota.”

Because of this, Garcia silenced Reistroffer, but then turned him off.

“You can’t silence a member of the public,” Reistroffer said breaking the silence. The action “further reinforces that it is a show committee.”

Garcia was silent again.

“The reason they gave that knight was for a lot of reasons,” Garcia said. He said they had “things online that were defaming me or what they were doing to me.”

He added: “I think I’ve been fair, more than fair, and it’s just a shame.”

In further public comment, Rep. Travis Ismay, R-Newell, who is not a member of the committee, complained that a state health inspector was seen hugging an industry representative outside the chamber. Ismay was the lead sponsor of the Garcia-sponsored bill to repeal the medical marijuana program, and previously tried to put a repeal initiative on the ballot.

“I don’t think they’re that reliable,” Ismay said of the industry in general.

Health Department Secretary Melissa Magstadt responded that no Health Department inspectors were present at the meeting. Ismay returned to the microphone, saying he “maybe misspoke or something,” claiming that he misidentified the people he saw.

Genesis Farms lobbyist Mitch Richter pointed to a previous board meeting in which Garcia, a physician, said a former patient of his used artificial intelligence to falsify documents to obtain medical marijuana, buy 3 ounces and sell them for $10,000 a week.

Richter said the allegations “do not hold water.”

“If you make $10,000 on 3 ounces of marijuana, I want to talk to you,” said Richter, who also said the commission should be repealed.

Reistroffer told the South Dakota Searchlight that 3 ounces of medical marijuana typically sell for around $600.

Garcia repeatedly defended the commission and himself, saying the panel was still in its oversight mandate and that the actions taken were “just motions.”

“For those who were disrespectful, shame on you,” he said.

Photo by Chris Wallis // Side Pocket Images.

Continue Reading

Cannabis News

Innovative substrate strategies boost plant production while reducing peat use

Published

on

By

Three recent studies from Dr. Jeb S. Fields’ Environmental Nursery Production Lab show that growers can reduce peat use in plant production by layering different substrate materials—a practice called substrate stratification—while maintaining plant growth or quality.

In the first study, the researchers tested how incorporating wood fiber into the bottom layers of containers affects plant growth. They found that using coarse wood fiber underneath and a finer moisture-retaining material on top helped the roots develop well, keeping the seedlings healthy and vigorous. The approach also offers growers the flexibility to tailor substrate mixes to specific crops or growing conditions.

A supporting study confirmed that layering low-peat and high-peat materials in the same container can significantly reduce overall peat use. Plants grown in these stratified mixtures performed as well or better than those grown in traditional uniform substrates.

A third study reinforces these findings, showing that stratified systems can cut total peat use while maintaining or improving plant quality compared to traditional uniform mixes.

Together, these findings give growers practical tools to reduce peat use, manage costs and achieve more sustainable production, all while maintaining the high-quality plants that customers expect.

Collectively, these findings provide practical strategies for nurseries and nurseries seeking to sustainably produce high-quality plants. By combining layered substrates, careful packaging and peat alternatives, growers can reduce peat dependence, improve root architecture and improve production efficiency.

These studies represent a step forward in sustainable gardening, demonstrating that environmentally responsible substrate management can go hand in hand with the production of high yielding plants.

According to Dr. Fields, “Researchers around the world have been looking for alternatives to peat for decades, but the answer may lie in managing the way we use the substrate we have. Through stratification, we can effectively reduce peat use by 50% without sacrificing plant growth or quality. Substrate stratification also allows the use of low-cost or recycled materials in place of permanent media and other sustainable growth materials and sustainable growth. Horticulture industry”.

The full article can be read on the ASHS HortTech e-journal website https://doi.org/10.21273/HORTTECH05570-24; https://doi.org/10.21273/HORTTECH05660-25; and https://doi.org/10.21273/HORTTECH05683-25

For more information:
American Society for Horticultural Science (ASHS)
ashlars.org

Continue Reading

Cannabis News

Striving for inclusivity in Caribbean cannabis market

Published

on

By











The government of Antigua and Barbuda has reiterated its intention to build a medical cannabis sector based on local empowerment, careful regulation and cultural respect. At a stakeholder dialogue organized by the Medicinal Cannabis Authority (MCA), officials presented a new roadmap for the development of medicinal cannabis on the island.

Addressing industry stakeholders, Attorney General Sir Steadroy Benjamin emphasized that the administration’s aim was to redirect the profits of this industry to people who have historically been shunned by foreign investors.

“I want to make it clear that my government (…) is fully committed to ensure that the economic benefits of this industry benefit the people of Antigua and Barbuda as a whole, and not just land investors,” he said, and to assure participants “that the pie is significant.”

This change comes as the authorities have acknowledged that previous economic initiatives in the country often concentrated profits in the hands of large operators. The government now wants to ensure that this trend is “ended”, with the new cannabis regulatory framework serving as a corrective model.

Read more at News Weed










Continue Reading

Cannabis News

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

Published

on

By

Only six percent of marijuana users approve of the Trump administration’s actions on cannabis policy so far, according to a new poll. Rumors abound that the president plans to direct federal rescheduling of cannabis.

The latest version of NuggMD and Marijuana Moment’s quarterly presidential approval tracking poll also found that 51 percent of respondents would support the current administration if marijuana were rescheduled or legalized.

Some President Donald Trump calls cannabis III. Despite the recent news that plans to reclassify the drug as Schedule I under the Controlled Substances Act are very positive, marijuana users’ support for the president’s marijuana “actions” declined in the last quarter.

1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent approve, a plurality of 38.4 percent are neutral, 26.1 percent disapprove and 29.5 percent strongly disapprove.

“Do you approve or disapprove of the presidential administration’s actions regarding cannabis?”
n: %
Strongly accept 7 1.6%
accept 20 4.5%
No opinion/Neutral 172 38.4%
Condemn 117 26.1%
Very disapproving 132 29.5%
448
Score (-50 to +50) -19,364
Clear Accept/Reject: -49.6%

However, the poll data also reinforced the idea that Trump could move the needle among cannabis-using voters by enacting key reforms, such as rescheduling or legalization.

It found that among respondents, 51 percent said they would change their level of support for the president if he took action on these reform proposals.

1.5 percent said they would support it less, while 47.5 percent said their opinion would not change.

“If the Trump administration were to reschedule or legalize cannabis, would that change your level of support?”
n: %
I would accept much more 172 38.4%
I could tolerate a bit more 56 12.5%
No change 213 47.5%
I would accept less 2 0.4%
I would accept much less 5 1.1%
448
Score (-50 to +50): 21,652
Clear Accept/Reject: 49.3%

“I find these data to be evidence that the White House needs to take tangible action on cannabis reprogramming to capture the clear political benefit of the public we poll, cannabis consumers who participate in state legal and regulated markets,” said Andrew Graham, chief communications officer for Nugg MD, Marijuana Moment.

“The trial balloon about the imminence of the overhaul is not going to cut it,” he said, adding that he doesn’t believe an executive leading the move to Schedule III “resolves the many problems with how federal law treats cannabis, a legal substance in many states.”

However, “I think it would benefit the industry and increase access, and consumers of cannabis would notice,” Graham said.

The latest quarterly poll found Trump’s overall approval rating among marijuana users down, from 11 percent in the previous quarter to around six percent this quarter.

The survey — which interviewed 448 cannabis users living in states with legal markets and has a margin of error of ±4.63 percentage points — was conducted before the president announced plans to move forward with the reorganization process initiated by the Biden administration, with deadlines for action ranging from Monday to early next year.

Trump confirmed Monday when asked by a reporter “very strongly” considering rescheduling cannabisHe said the reform “brings in enormous amounts of research that can’t be done if you don’t reclassify.”

Amid rumors of a reconsideration, top Democrats in Congress have complained that the reform would not go far enough, including Sen. Ron Wyden (D-OR) who called the move only a tentative one. president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval rating.

Meanwhile, it is an important organization in the drug testing industry Amid ‘sounding the alarm’ reports Trump may soon end marijuana reregulation proposalthat the reform would have “catastrophic consequences for the safety of US workers and the transportation sector.”

Cannabis industry players are hopeful that reform will be passed as soon as possible, but opponents — including the National Drug and Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM) — are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marihuana Moment that no action has been taken so far.

They have been bipartisan members of Congress weighing a possible decision to reorganize last week—Democrats like Rep. Alex Ocasio-Cortez (D-NY) call the reform a “no” and others like Rep. Andy Harris (R-MD) have pushed back against the proposal.

Trump said this in mid-August he would make the reorganization decision in a week. But despite that timeline and increasing rumors, a White House spokesman told Marijuana Moment last week that “no final decision has been made on rescheduling marijuana.”

The Washington Post reported Thursday afternoon that Trump planned to issue an executive order to federal agencies to move ahead with cannabis rescheduling.

The outlet also said the president met with marijuana industry executives Robert F. Kennedy Jr. earlier this week in the Oval Office. with Secretary of Health and Human Services and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump called Johnson, the House Speaker, who opposed the rescheduling of cannabis,

If the administration ultimately enacts the rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition half a century ago, when it was banned under Article III. With a reclassification, marijuana has medical value and a lower abuse potential compared to Schedule I drugs like heroin.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Trump endorsed the rescheduling — as well as an initiative to legalize access to industrial banking and adult use in Florida — on the campaign trail. The president had been silent on the issue since taking office for a second term, until a meeting in August where, in response to a reporter’s question, he announced that the administration would decide to reschedule in a few weeks.

The possibility of an immediate rescheduling announcement comes a few weeks later the president signed a major spending bill that would effectively ban most consumer hemp productsdrawing criticism from hemp industry players who say the policy change would wipe out the market.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media